T2G.F
Tradegate AG Wertpapierhandelsbank
FrankfurtEUREQUITY
DELAYED
Last price
81.50
▼ 0.50 (0.61%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
81.50
Prev close
82.00
Day high
81.50
Day low
81.50
Volume
5
Market cap
—
P/E (TTM)
—
52W range
81.00 – 92.50
Day trading desk
Gap from prior close
-0.61%
Prior close 82.00
VWAP
—
—
Relative volume
—
—
Session range
—
81.50 – 81.50
Position in range
—
—
ATR (14D)
0.29
0.35% of price
Prior day high
82.00
PDH
Prior day low
82.00
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.98%
-1.9%
1M
-2.98%
-6.4%
3M
-6.86%
-9.4%
6M
-4.68%
-16.7%
YTD
-5.23%
-17.3%
1Y
-6.86%
-27.1%
3Y
-25.23%
-100.5%
5Y
-33.20%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on T2G.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $190.34M | $134.25M | $104.15M | $144.27M | +41.8% |
| Operating revenue | $190.34M | $134.25M | $104.15M | $144.27M | +41.8% |
| Selling, general & admin | $78.14M | $50.86M | $37.70M | $40.14M | +53.6% |
| Total operating expense | $119.19M | $87.66M | $68.49M | $69.44M | +36.0% |
| Pre-tax income | $75.29M | $43.82M | $34.90M | $69.32M | +71.8% |
| Tax provision | $22.92M | $14.42M | $11.45M | $23.55M | +58.9% |
| Net income | $51.27M | $29.39M | $23.45M | $45.77M | +74.4% |
| Net income to common | $51.27M | $29.39M | $23.45M | $45.77M | +74.4% |
| Basic EPS | 2.10 | 1.46 | 0.96 | 2.21 | +44.3% |
| Diluted EPS | 2.10 | 1.46 | 0.96 | 2.21 | +44.3% |
| Basic shares | 24.38M | 20.17M | 21.35M | 20.73M | +20.8% |
| Diluted shares | 24.38M | 20.17M | 24.39M | 20.73M | +20.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.15M | $914.34K | $861.65K | $83.16M | +25.9% |
| Property, plant & equipment | $4.78M | $5.29M | $6.19M | $4.49M | -9.5% |
| Goodwill & intangibles | $13.82M | $17.74M | $12.96M | $10.86M | -22.1% |
| Total assets | $411.20M | $390.45M | $323.57M | $343.21M | +5.3% |
| Total liabilities | $257.06M | $258.33M | $197.51M | $199.40M | -0.5% |
| Retained earnings | $121.72M | $99.49M | $93.28M | $110.02M | +22.3% |
| Shareholder equity | $154.14M | $132.12M | $126.06M | $143.81M | +16.7% |
| Net tangible assets | $140.31M | $114.38M | $113.09M | $132.95M | +22.7% |
| Shares issued | 24.40M | 24.40M | 24.40M | 24.40M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $51.27M | $29.39M | $23.45M | $45.77M | +74.4% |
| Depreciation & amortisation | $5.39M | $4.63M | $1.81M | $1.18M | +16.4% |
| Change in working capital | -$4.27M | $11.99M | $19.73M | -$17.18M | -135.6% |
| Operating cash flow | $65.57M | $70.71M | $52.44M | $27.67M | -7.3% |
| Capital expenditure | -$965.00K | -$8.38M | -$5.71M | -$4.39M | +88.5% |
| Investing cash flow | -$965.00K | -$8.38M | -$5.71M | -$4.64M | +88.5% |
| Share buybacks | -$1.18M | -$4.03M | -$2.97M | -$4.16M | +70.6% |
| Dividends paid | -$29.25M | -$21.94M | -$41.46M | -$97.48M | -33.3% |
| Financing cash flow | -$29.25M | -$23.33M | -$41.19M | -$96.27M | -25.3% |
| Free cash flow | $64.60M | $62.33M | $46.73M | $23.28M | +3.6% |
| End cash position | $340.48M | $305.12M | $266.13M | $260.59M | +11.6% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $1.15M | $1.06M | $914.34K | +8.4% |
| Property, plant & equipment | $4.78M | $4.99M | $5.29M | -4.0% |
| Goodwill & intangibles | $13.82M | $15.58M | $17.74M | -11.3% |
| Total assets | $411.20M | — | $390.45M | — |
| Total liabilities | $257.06M | — | $258.33M | — |
| Retained earnings | $121.72M | — | $99.49M | — |
| Shareholder equity | $154.14M | — | $132.12M | — |
| Net tangible assets | $140.31M | $115.54M | $114.38M | +21.4% |
| Shares issued | 24.40M | — | 24.40M | — |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
83.25
-2.10% from price
SMA 20
83.63
-2.54% from price
SMA 50
84.22
-3.23% from price
SMA 100
84.96
-4.07% from price
SMA 200
85.44
-4.61% from price
EMA 12
83.05
-1.87% from price
EMA 26
83.62
-2.54% from price
EMA 50
84.12
-3.12% from price
RSI (14)
12.2
Oversold
MACD (12,26,9)
-0.57
Hist -0.23
ATR (14)
0.29
0.35% of price
Realised vol 30D
9.1%
Annualised
Bollinger upper
85.20
20, 2σ
Bollinger lower
82.05
20, 2σ
50 / 200 cross
Death
84.22 vs 85.44
Trend bias
Below 200
-4.61%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.05
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
9.1%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-12.4%
Peak to trough
Max drawdown 5Y
-35.7%
Peak to trough
ATR 14
0.29
0.35% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Bill Ackman's Pershing Square is reportedly taking a $1.12 billion stake in Visa.
Yahoo Finance · 4m ago
Value per Security
Business Wire · 5m ago
Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval
Medical Device Network · 7m ago
FRN Variable Rate Fix
Business Wire · 9m ago
OpenCV Launches New AI Competition powered by Amazon Web Services
PR Newswire · 9m ago
3 Reasons to Sell NNBR and 1 Stock to Buy Instead
StockStory · 10m ago
Which NFL stadiums are best? Atlanta ranked second in the nation
USA TODAY · 10m ago
Holland America Evolution Expands Live Music Offerings with New Poolside Bandstands on Oosterdam and Zuiderdam
PR Newswire · 10m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.